 |  Europe |
|
|
|  |  |  |  |  |  | |
|
|  | | newsHealthcare Market Review |
|
|
|
|
Home > Europe Home > News > Publications > Healthcare Market Review > Back Issues | |
|
|
|
Healthcare Market Review
|
October 2007 IssueCompeting interests in coronary heart disease.Critical illness policies, despite the name, have always covered a blend of medical diagnoses and surgical operations. Indian health insurance – a major opportunity?Since the last update on the Indian health insurance sector in the October 2005 Healthcare market review, both the healthcare provision and the health insurance markets have undergone significant change. Healthcare reforms in Central and Eastern EuropeHealthcare financing and provision is changing throughout Central and Eastern Europe (CEE). This article provides an overview of the systems, reforms and financing in three of the post-communist countries in the region – Hungary, the Czech Republic and Slovakia. Private medical insurance in Ireland2007 is the 50th anniversary of the state-owned VHI, the original private medical insurance (PMI) company in Ireland. Since the introduction of PMI in Ireland, it has proven to be a popular and valued product. Gender as a rating factor – the impact of the EU Equality Directive on the UKIn June 2007, Her Majesty’s Treasury department published its consultation paper, The publication of data associated with the use of gender in the assessment of insurance risks, regarding the implementation of the EU Equality Directive. April 2007 IssueThe widening gulf between diagnosis and critical illness claims for multiple sclerosisThe widespread medical and public interest in cancer screening programmes and the provision of primary prevention are based on the tenet that detection of disease at an early stage provides the opportunity for treatment that may either delay or prevent further disease and death. Group insurances in the UK – achieving their potential?The provision or facilitation of various types of insurance through employers is a well established practice in the UK. Collectively, these group insurances accounted for premium revenue for insurers in excess of £3 billion in 2005. However, there is much to suggest that this figure could, and perhaps should, be even higher. Healthcare guarantees – understanding the implicationsFor many years critical illness (CI) was the fastest growing healthcare product line in the UK, however new sales have been declining since their peak in 2002. Health insurance costs in the Netherlands – the changing pattern of hospital and specialist care costsFrom 1 January 2005, the way in which hospital and specialist care costs were financed in the Netherlands changed. October 2006 IssueCritical illness – providing lessons for predicting future mortality?Considering whether critical illness data can help with a better understanding of mortality. ABI Statement of Best Practice for critical illness – what does it all mean?Analysing the impact of the changes to the UK’s standard critical illness definitions. Russian health insuranceAn overview of the health system, the insurance market and the key issues providers face. The changing Dutch healthcare systemThe new system and the impact on the Dutch population and its insurers. April 2006 IssueA new front in the war on cancer in the UKThe latest initiative on one of the core critical illnesses and the potential implications. Pensions term assurance - assessing the opportunityAnalysing the impact of this catalyst for change in the UK protection markets. A healthy future for European voluntary health insurance markets?Assessing the issues and potential in Europe for voluntary health insurance. Healthcare protection in the Asia Pacific regionAn overview of the market for health related insurances (including critical illness) in selected territories. October 2005 IssueStroke – a Fractured Future in Critical Illness?Developments in the diagnosis and treatment of one of the core critical illnesses. The Health Insurance Industry in India and its Growing PotentialKey issues facing the health insurance sector in one of the world’s fastest growing economies. The ‘Fair’ Treatment of Reviewable Premium Protection Business.What has been happening to reviewable premiums. The Changing Disability System in the NetherlandsThe reforms in the Dutch disability system and the consequences for private insurers. April 2005 IssueAnalysing HealthThe application of generalised linear modelling for medical expenses insurance and mortality risk. All Change in the Protection Markets?The impact of the Treating Customers Fairly and Pensions Simplication regulations. Proteomics and DNA Micro-arrays – A Brave New World for the Early Detection of Cancer?Advancements in cancer screening and the implications for insurers. Taking the 'In' Out of 'Incapacity'A further opportunity for the income protection market? October 2004 IssueCritical illness in the United StatesSue Elliott looks at the emerging US critical illness market. Healthy competition in Ireland?Rosemary Commons and Mike Williams consider the Irish health insurance market. The Singapore health system – achieving positive health outcomes with low expenditureJohn Tucci explores the current set-up. Reforms in the Dutch health systemThe Dutch government is contemplating the introduction of a ‘standard medical care insurance’ with effect from January 2006. Maud Rommers describes the plans. April 2004 IssueWill continued improvements in mortality founder on the ‘icebergs’ of obesity and diabetes?Daniel Ryan explores the issues. An opportunity for healthy partnerships?Mike Williams considers the potential for health-related partnerships. Individual capital assessment in the health and protection marketsSue Elliott explains the considerations. Social security changes, IFRS and IT – a ‘win-win’ way ahead for the disability market in the Netherlands?Maud Rommers and Bart Kling highlight how timely investments in IT could lead to potential upsides from some unavoidable changes. October 2003 IssueGuarantees and health protection productsThe cost of guarantees on health protection products has become a more pressing issue for the UK insurance industry. Andy Sanders explains... Prostate cancer – a case study on the importance of communicationDaniel Ryan highlights the lessons to learn from the UK’s critical illness experience... An overview of disability and medical insurances in the NetherlandsMaud Rommers describes the current set up and the plans for future reforms... The changing solvency requirements for long-term class IV businessAndy Sanders and Sue Elliott describe the changes and consider some of the implications for UK insurers... Predictive modelling in US healthcareMay Lee Low explains the reasons for, and the current status of, predictive modelling of healthcare costs in the US... Protection insurance distributionRecent proposals for regulatory change in the UK suggest protection insurance distribution is entering a new era. Frank Fletcher examines some of the likely effects... The changing stance at the Financial Services OmbudsmanSue Elliott considers recent rulings by the UK’s Financial Services Ombudsman and takes us through what’s been happening... April 2003 IssueDaring to understand mortalityMortality has long been an integral part of the fortunes of insurance companies, pension funds and the actuarial profession... An overview of the Spanish health insurance marketThe Spanish health insurance market has experienced sustained growth over the past decade... Critical illness - in need of a makeover?From its beginnings in the early 1990s to a product that now provides cover to perhaps as much as 15% of the working population, critical illness can rightly be considered one of the UK insurance industry's successes... Healthcare in IndiaAlthough over the last 50 years, India has shown some improvements in its health infrastructure, it is at a far from satisfactory level... PMI in crisis?Although still showing overall growth, the UK private medical insurance (PMI) market has been making news in recent months... October 2002 IssueWho’s scared of critical illness?The critical illness product has been a major marketing success for the UK insurance industry. However the question that is increasingly being asked by both direct ... Experience analysis - an income protection case studyThe previous issue of Healthcare Market Review focused on the importance of the experience monitoring function within the overall management of the control cycle... Cancer insurance products in Asian marketsCancer insurance is one of the major product classes in the Japanese, Korean and Taiwanese insurance markets... A different perspective - the Australian health systemThe UK health system continues to generate headlines on a week by week basis... Funding healthcare globally: multinationals look to captivesWith global expansion continuing through partnerships or acquisitions, business is evolving into giant networks of entities dispersed around the globe... July 2002 IssueWhat’s in a name?No one could accuse the broad health insurance industry of making it easy for customers. PMI, IPI, CIC, LTC, ASU to name but five TLAs (three letter acronyms) all address differing facets of ‘health’ insurance. Experience monitoring – the importance and the processThe underlying nature of the healthcare insurance risk is much more complex than the traditional life insurance risk. Product pricing policyIn today’s health and financial services markets, ‘value for money’ is a fundamental goal for consumers, product providers and the Government alike. Disability, absence and productivity management in the USOver the last several years, the US market has seen employer interest move from Integrated Disability Management (IDM), towards Total Absence Management (TAM)... October 2001 IssueAre the elderly driving up the cost of UK healthcare?The common consensus across all developed countries has been that ageing populations will have a significant impact on a wide range of public policy areas, including healthcare. Affinity MarketingIs the workplace the best affinity opportunity for healthcare? Understanding Managed Care Organisations’ (MCOs) underwriting strategies and their impactLessons from the USA Healthcare statisticsWorld health systems |
|
|
| Copyright© 2008 Watson Wyatt Worldwide. All rights reserved. Authorised and regulated by the financial services authority. |
